Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Name: Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
SKU: 3076
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 3 Articles Tags: abrupt-switch, clozapine, crossover, medworks-media, michael-w-jann, olanzapine, pharmacodynamics, pharmacokinetics, psychopharmacology-bulletin, richard-m-bunt, switching-antipsychotics, ziprasidone

Description

Description

Michael W. Jann, PharmD, FCCP, BCPP

DRUG DISPOSITIONS AND PHARMACOKINETICS

Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

switching antipsychotics, pharmacokinetics, pharmacodynamics, crossover, abrupt switch, clozapine, olanzapine, ziprasidone

Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Description

Michael W. Jann, PharmD, FCCP, BCPP

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

What Mood Symptoms may be most Difficult to Rate?

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas

Michael W. Jann, PharmD, FCCP, BCPP: Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective

Description

Michael W. Jann, PharmD, FCCP, BCPP

Related products

Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj

What Mood Symptoms may be most Difficult to Rate?

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas